Gilead Sciences Inc. (GILD)

Profile

https://www.gilead.com

Gilead Sciences Inc. is a biopharmaceutical company that discovers, develops, and commercializes medicines addressing unmet medical needs in infectious diseases, oncology, and inflammatory conditions across the United States, Europe, and other international markets. Its portfolio centers on HIV treatments, including single-tablet regimens like Biktarvy, Genvoya, Descovy, Odefsey, and Sunlenca, which offer convenient and effective options for HIV-1 management. The company also provides therapies for viral hepatitis such as Epclusa, Harvoni, Vemlidy, and Livdelzi for chronic hepatitis C, primary biliary cholangitis, and hepatitis B. In oncology, Gilead Sciences Inc. advances innovative treatments through CAR T-cell therapies Yescarta and Tecartus for certain lymphomas, as well as Trodelvy for breast and bladder cancers. Additionally, it offers Veklury for COVID-19 treatment. Founded in 1987 and headquartered in Foster City, California, Gilead Sciences Inc. plays a vital role in global healthcare by delivering specialized antiviral, liver disease, and cancer therapies to patients worldwide.